Analyst
Macquarie Capital
Equibles does not estimate personal net worth.
Dr. Kunal Damesha is recorded as Analyst at Macquarie Capital. Dr. Kunal Damesha has spoken on 3 earnings calls across 3 companies, most recently for Cohance Lifesciences Limited on November 6, 2026. Those appearances were for Cohance Lifesciences Limited, Sun Pharmaceutical Industries Limited and Mankind Pharma Limited. The companies whose calls Dr. Kunal Damesha spoke on are classified in the Healthcare sector.
“The first question is on the two additional commercial projects. That we have kind of caught in this quarter. Umang, if you could highlight the nature of these projects, you know, in terms of whether these end products are paid and protected, are they from innovative companies?”
“First one on the slowdown in growth for Lumia in US. Rick, can you highlight what is driving that and what kind of actions we have Yeah,”
“First question for Rajiv, sir, on, you know, some of the disruption that we had witnessed in FY26, you know, in some of our teams, and we had done a lot of hiring, you know, and they were undergoing training, etc. So, where do you put progress on those aspects now?”
Macquarie Capital
Analyst
Transcript header (unverified)
Cohance Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Mankind Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Cohance Lifesciences Limited
Earnings Call
Sun Pharmaceutical Industries Limited
Earnings Call
Mankind Pharma Limited
